Literature DB >> 12220953

Effects of paracetamol and propacetamol on gastric mucosal damage and gastric lipid peroxidation caused by acetylsalicylic acid (ASA) in rats.

B Galunska1, K Marazova, T Tankova, A Popov, P Frangov, I Krushkov, A Di Massa.   

Abstract

We have studied the effect of paracetamol and its pro-drug propacetamol on gastric mucosal damage induced by acetylsalicylic acid (ASA) and its possible relation to changes in gastric lipid peroxidation status in rats. Paracetamol or propacetamol were administered intragastrically 1h before ASA (300 mg kg(-1)) in the following equivalent doses: 62.5, 125.0 and 250.0 mg kg(-1) or 125.0, 250.0 and 500.0 mg kg(-1), respectively. The effects of the tested agents were compared to that of prostaglandin E2 (PGE2) 15, 30 and 60 mg kg(-1). Gastric ulcer formation was estimated morphometrically 4h after ASA administration. Malondialdehyde (MDA), glutathione (reduced, GSH, and oxidized, GSSG) and uric acid (UA) were determined in gastric mucosa and blood plasma and used as biochemical markers of the oxidative status. The results showed that paracetamol (250, 125, 62.5 mg kg(-1)) and propacetamol (500, 250, 125 mg kg(-1)) diminished the area of ASA-induced gastric lesions. The effect of propacetamol was more pronounced than that of paracetamol and similar to that of PGE2. Gastric MDA increased 3-fold in the ASA-group. The tested agents reduced it by a range of 30-70%. In all pretreated groups gastric glutathione and UA levels were found higher than that of control group and lower than that of ASA-group. Paracetamol and propacetamol, as well as PGE2, diminished the lipid peroxidation in plasma to a lesser extent than in gastric mucosa, but maintained elevated levels of the selective plasma antioxidant UA. These results show that the ASA-induced gastric mucosal damage is accompanied by the development of oxidative stress, evidenced by the accumulation of MDA, and concomitant initial activation of cell antioxidant defences. As paracetamol and propacetamol tend to decrease gastric lesions caused by ASA and alter gastric mucosal MDA, glutathione and UA values in a favorable manner, it could be suggested that their effects on the gastric mucosa could be related to interference with oxidative stress development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220953     DOI: 10.1016/s1043-6618(02)00083-x

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Effects of melatonin or acetylsalicylic acid on gastric oxidative stress after bile duct ligation in rats.

Authors:  Alaaddin Polat; Memet Hanifi Emre
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy.

Authors:  Timothy R Koch; Ann Petro; Marcus Darrabie; Emmanuel C Opara
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Protective effect of melatonin against multistress condition induced lipid peroxidation via measurement of gastric mucosal lesion and plasma malondialdehyde levels in rats.

Authors:  V Kiarostami; L Samini; M Ghazi-Khansari
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

4.  Hydroethanolic extract of Baccharis trimera promotes gastroprotection and healing of acute and chronic gastric ulcers induced by ethanol and acetic acid.

Authors:  Francislaine Aparecida Dos Reis Lívero; Luisa Mota da Silva; Daniele Maria Ferreira; Larissa Favaretto Galuppo; Debora Gasparin Borato; Thiago Bruno Lima Prando; Emerson Luiz Botelho Lourenço; Regiane Lauriano Batista Strapasson; Maria Élida Alves Stefanello; Maria Fernanda de Paula Werner; Alexandra Acco
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-06-17       Impact factor: 3.000

5.  Repeated administration of the NSAID meloxicam alters the plasma and urine lipidome.

Authors:  Sol M Rivera-Velez; Liam E Broughton-Neiswanger; Martin Suarez; Pablo Piñeyro; Jinna Navas; Sandy Chen; Julianne Hwang; Nicolas F Villarino
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.